Stocks › LH
LABCORP HOLDINGS INC.
LH·NYSE·
United States·USD
United States·USD$311.97
+0.26 (+0.08%)
Close · Oct 7, 2026 · Close Prices from Tiingo.com
LH
LABCORP HOLDINGS INC. · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
LHS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
Congressional Trades
Recent trades of LH by members of U.S. Congress · 71 on record · 18 in the last 12 months
Whale Activity
Position changes in LH reported for 2026-09-30 by 1 tracked institutional filer
- Increased0
- New0
- Held0
- Decreased0
- Closed0
- No prior filing1
| Filer | Shares | Value | Change |
|---|---|---|---|
| AMERICAN NATIONAL BANK & TRUST | 46.0K | $14.2M | — |
KeyVex tracks a curated set of large 13F filers plus the largest positions in recent filings, so this is a sample of institutional activity, not the whole market.
Insider Trading
Net shares bought (+) or sold (−) on the open market by LH insiders, by quarter · Form 4
Recent Insider Transactions
4,165 transactions on record · newest first
| Insider | Type | Shares | Price | Value | Date | |
|---|---|---|---|---|---|---|
| ANDERSON KERRII BDirector · Director | Sale | −3,000 | $318.02 | $954K | Aug 17, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −4,669 | $320.37 | $1.5M | Aug 11, 2026 | Form 4 ↗ |
| Summy Amy B.EVP, Chief Marketing Officer | Sale | −924 | $306.74 | $283K | Aug 4, 2026 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −82 | $309.22 | $25K | Aug 3, 2026 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −1,338 | $309.23 | $414K | Aug 3, 2026 | Form 4 ↗ |
| Kyle Kathryn WEVP, Chief Legal Officer | Sale | −92 | $286.19 | $26K | Jul 2, 2026 | Form 4 ↗ |
| Vaughn Bryan TEVP and President, Diagnostics | Sale | −234 | $286.19 | $67K | Jul 2, 2026 | Form 4 ↗ |
| Kyle Kathryn WEVP, Chief Legal Officer | Sale | −762 | $263.89 | $201K | Jun 8, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Sale | −5,903 | $254.50 | $1.5M | May 11, 2026 | Form 4 ↗ |
| Wilkinson Peter JSVP, Chief Accounting Officer | Sale | −1,633 | $267.05 | $436K | Mar 27, 2026 | Form 4 ↗ |
| Meltzer Jonathan CEVP, Operations | Sale | −839 | $267.05 | $224K | Mar 27, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Tax withholding | −26.1K | $268.38 | $7.0M | Mar 26, 2026 | Form 4 ↗ |
| Schechter Adam HPresident & CEO · Director | Grant / award | +58.5K | $0.00 | $0 | Mar 26, 2026 | Form 4 ↗ |
| GRAHAM ANITA ZEVP, CHRO | Tax withholding | −2,879 | $268.38 | $773K | Mar 26, 2026 | Form 4 ↗ |
| GRAHAM ANITA ZEVP, CHRO | Grant / award | +6,604 | $0.00 | $0 | Mar 26, 2026 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Tax withholding | −1,468 | $268.38 | $394K | Mar 26, 2026 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Grant / award | +2,968 | $0.00 | $0 | Mar 26, 2026 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Tax withholding | −4,600 | $268.38 | $1.2M | Mar 26, 2026 | Form 4 ↗ |
| Schroeder Mark SEVP, Pres Diagnostics & COO | Grant / award | +9,304 | $0.00 | $0 | Mar 26, 2026 | Form 4 ↗ |
| Caveney Brian JEVP, Pres of ED, CMO & CSO | Tax withholding | −863 | $268.38 | $232K | Mar 26, 2026 | Form 4 ↗ |
Fund Holders
Mutual funds and ETFs holding LH · SEC Form N-PORT
| Fund | Shares | Value | % of fund | As of |
|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 2.6M | $729.1M | 0.03% | Jun 30, 2026 |
| VANGUARD 500 INDEX FUND VANGUARD INDEX FUNDS | 2.1M | $594.9M | 0.04% | Jun 30, 2026 |
| VANGUARD MID-CAP INDEX FUND VANGUARD INDEX FUNDS | 1.8M | $497.5M | 0.22% | Jun 30, 2026 |
| Allspring Special Mid Cap Value Fund ALLSPRING FUNDS TRUST | 1.5M | $430.1M | 3.19% | Jun 30, 2026 |
| Victory Sycamore Established Value Fund Victory Portfolios | 1.4M | $404.6M | 2.62% | Jun 30, 2026 |
| iShares Core S&P 500 ETF iShares Trust | 1.1M | $315.9M | 0.04% | Jun 30, 2026 |
| Victory Pioneer Fund Victory Portfolios IV | 1.1M | $294.5M | 2.63% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P 500(R) ETF Trust | 994.1K | $278.3M | 0.04% | Jun 30, 2026 |
| Fidelity 500 Index Fund Fidelity Concord Street Trust | 1.1M | $275.9M | 0.03% | May 31, 2026 |
| VANGUARD VALUE INDEX FUND VANGUARD INDEX FUNDS | 779.8K | $218.4M | 0.09% | Jun 30, 2026 |
Mutual funds and ETFs whose N-PORT filings list LH's shares (CUSIP 504922105), each fund at its latest report since Mar 8, 2026, largest positions first. Bonds, options and short positions are left out.
Activist & Passive Stakes
Schedule 13D / 13G beneficial-ownership filings
No 13D/13G beneficial-ownership filings on record.
Corporate Lobbying
Estimated quarterly lobbying spending reported under the LDA, filings naming LABCORP HOLDINGS INC. as client
No lobbying filings found naming LABCORP HOLDINGS INC. as the client.
Government Contracts
Federal awards to LABCORP HOLDINGS INC. · USAspending
No federal contract awards found for LABCORP HOLDINGS INC..
U.S. Patents
Recent USPTO applications naming LABCORP HOLDINGS INC.
No USPTO patent applications found for LABCORP HOLDINGS INC..
Annual Financials
From LH's 10-K filings · XBRL
No annual XBRL figures on record for LH. KeyVex's fundamentals cover about 130 large companies so far.
Stock Splits
Every split and reverse split in the price history
- 43-for-37Stock splitJul 3, 2023
- 2-for-1Stock splitMay 13, 2002
- 2-for-1Stock splitJun 12, 2001
- 1-for-10Reverse splitMay 4, 2000
Split dates and ratios from the price history · Close Prices from Tiingo.com
Material Events (8-K)
Corporate events filed with the SEC
- 8-K · Items 7.01, 9.01Reg FD disclosureSep 30, 2026
EDGAR ↗ - 8-K · Items 7.01Reg FD disclosureSep 22, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureSep 10, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureAug 28, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureAug 17, 2026
EDGAR ↗ - 8-K · Items 5.02Officer / director changeAug 14, 2026
EDGAR ↗ - 8-K · Items 2.02, 9.01Results of operationsJul 30, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureJun 30, 2026
EDGAR ↗ - 8-K · Items 7.01, 9.01Reg FD disclosureMay 27, 2026
EDGAR ↗ - 8-K · Items 5.07Shareholder voteMay 26, 2026
EDGAR ↗
About LABCORP HOLDINGS INC.
From SEC EDGAR company records
Industry (SIC 8071)Services-Medical Laboratories
SectorHealthcare
HeadquartersBURLINGTON, NC
SEC CIK0000920148 ↗
Former namesLABORATORY CORP OF AMERICA HOLDINGS, NATIONAL HEALTH LABORATORIES HOLDINGS INC